WASHINGTON, Oct. 14 -- Food and Drug Administration has issued a notice called: Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal.

The notice was published in the Federal Register on Oct. 14 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA) is announcing the renewal of the Cellular, Tissue, and Gene Therapies Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Cellular, Tissue, and Gene Therapies Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect unti...